Organization
Altoona Center for Clinical Research, Duncansville
2 abstracts
Abstract
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SEQUENTIAL-DOSE STUDY OF THE SAFETY OF APRATASTAT (TMI-005), A NOVEL ORAL DUAL INHIBITOR OF TNF-ALPHA-CONVERTING ENZYME/METALLOPROTEINASE, IN PATIENTS WITH RHEUMATOID ARTHRITIS ON A BACKGROUND OF METHOTREXAOrg: Research Center for Health Policy and Economics, Radiant Research, Dallas, Altoona Center for Clinical Research, Duncansville, Duncansville,
Abstract
A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION STUDY OF SUMMACTA AND BREVACTA TO EVALUATE SAFETY AND EFFICACY OF TOCILIZUMAB SC IN PATIENTS WITH MODERATE TO SEVERE RA Org: Altoona Center for Clinical Research, Duncansville, University of Nevada School of Medicine, Las Vegas, Clinical Research Center of Reading, Reading, Genentech, South San Francisco, United States,